CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Reyoung Pharmaceutical Holdings Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Reyoung Pharmaceutical Holdings Limited
No.6 Erlangshan Road, Yi Yuan County
Phone: +86 5333237275p:+86 5333237275 ZIBO, SDG  256100  China Ticker: R12R12
Business Summary
Reyoung Pharmaceutical Holdings Limited is an investment holding company. The Company operates in two segments: pharmaceutical segment and the personal hygiene segment. Its pharmaceutical products are sold principally under its Reyoung brand name. The Company’s pharmaceutical products include penicillin-based antibiotics, traditional chinese medicine (TCM) formulated products, cephalosporin-based antibiotics and western medicine. Its personal hygiene products segment consists of sanitary napkins and disposable baby diapers. Its sanitary napkins and pantyliners are sold under its Yimu brand name. The Company also manufactures and sells disposable baby diapers under its own brand names Yibei and Tiaopidan.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201012/31/2009Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2676 Sanitary paper products
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board YushanZhao 12/3/2004
Chief Financial Officer JinkeZhang
Group Financial Controller, Deputy Company Secretary WaiPing Leung 69 7/1/2008 7/1/2008
10 additional Officers and Directors records available in full report.

Business Names
Business Name
R12
Reyoung Pharmaceutical Holdings Limited

General Information
Number of Employees: 2,247 (As of 12/31/2005)
Outstanding Shares: 313,420,000 (As of 12/31/2010)
Shareholders: 756
Stock Exchange: SIN
Fax Number: +86 5333227272


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023